We are currently recruiting for..
£4,750 + reasonable travel expenses
Participants with idiopathic pulmonary fibrosis (IPF) needed for the study of a potential new medicine to treat progressive multiple sclerosis and IPF. You must be aged 25 to 65, with a BMI between 18 and 30.9. Women must be post-menopausal for at least 1 year or surgically sterilised. This study involves 1 screening visit, up to 6 nights’ residence on our ward and 2 outpatient visits. You’ll have a total of 3 PET scans. Starts 4 March 2025.
£4,865 + reasonable travel expenses
Participants with progressive multiple sclerosis (MS) needed for the study of a potential new medicine to treat MS and idiopathic pulmonary fibrosis (IPF). You must be aged 25 to 65, with a BMI between 18 and 30.9. Women must be post-menopausal for at least 1 year or surgically sterilised. This study involves 2 screening visits (including 1 MRI scan), up to 6 nights’ residence on our ward and 2 outpatient visits. You’ll have a total of 3 PET scans. Starts 24 February 2025.
Healthy participants needed for the study of a potential new medicine for progressive multiple sclerosis (MS) and idiopathic pulmonary fibrosis (IPF). You must be aged 25 to 65, with a BMI between 18 and 30.9. Women must be postmenopausal for at least 1 year or surgically sterilised. It involves 2 screening visits (including 1 MRI scan), 3 nights’ residence, and 2 outpatient visits. You’ll have a total of 3 PET scans. Next admission on 20 January 2025.
Healthy participants needed for the study of a potential new medicine for progressive multiple sclerosis (MS) and idiopathic pulmonary fibrosis (IPF). You must be aged 25 to 65, with a BMI between 18 and 30.9. Women must be postmenopausal for at least 1 year or surgically sterilised. This study involves 1 screening visit, 3 nights’ residence, and 2 outpatient visits. You’ll have a total of 3 PET scans. Next admission on 21 January 2025.
£10,650 + reasonable travel expenses
Participants with mild to moderate asthma needed for the study of a potential new medicine to treat the condition. You must be aged 18 to 65, with a BMI between 18 and 32, weigh at least 45 kg and not have used any nicotine products for at least 12 months. It involves 2 sessions of 4 nights’ residence on our wards, 16 outpatient visits, and 1 phone call. Next admissions on 20 and 28 January 2025.
Healthy participants needed for the study of a potential new treatment for treatment-resistant depression. The study drug is a man-made form of a natural psychedelic drug. You must be aged 18 to 64, have a BMI between 18.5 and 35, and not have used any nicotine products in the last 6 months. Women able to have a baby must be on contraception. It involves 1 night’s residence, 2 telephone calls, 1 video-call, and 1 follow-up. Next admissions expected in February 2025.
Healthy men needed for the study of a potential new medicine for treating autism spectrum disorder (ASD). You must be aged 18 to 55, have a BMI between 18.5 and 32, weigh at least 40 kg, and not have used any nicotine products in the last 3 months. This study involves 1 session of 3 nights’ residence, 2 outpatient visits and 1 follow-up appointment. Admissions on 29 January and 3 February 2025.
£2,250 + reasonable travel expenses
People with treatment resistant depression (at least 2 failed treatments) needed for the study of a potential new medicine for treating the condition. You must be aged 18 to 75. You can’t take part if you’ve used any psychedelic substances in the last 6 months. It involves 2 sessions of 1 night’s residence, and 11 outpatient visits (some of them can be video calls). Admissions regularly until January 2025.